Protein kinase C-delta is involved in the inflammatory effect of IL-6 in mouse adipose cells

E Wallerstedt1, U Smith, C X Andersson

  • 1The Lundberg Laboratory for Diabetes Research, Center of Excellence for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine/Diabetes, The Sahlgrenska Academy at University of Gothenburg, Blå Stråket 5, SE-413 45, Gothenburg, Sweden.

Diabetologia
|February 13, 2010
PubMed
Abstract

Insights

Protein kinase C-delta (PKCdelta) is crucial for IL-6-induced inflammation in fat cells by phosphorylating STAT3. Inhibiting PKCdelta reduces inflammatory gene activation, suggesting it as a therapeutic target.

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Inflammation research

Background:

  • Interleukin-6 (IL-6) is a key cytokine in inflammatory processes.
  • Signal transducer and activator of transcription 3 (STAT3) is a critical mediator of IL-6 signaling.
  • Protein kinase C-delta (PKCdelta) involvement in cellular responses is increasingly recognized.

Purpose of the Study:

  • To investigate the role of PKCdelta in IL-6-induced STAT3 phosphorylation.
  • To determine PKCdelta's effect on inflammatory gene activation in adipose cells.
  • To explore PKCdelta as a potential therapeutic target for IL-6-mediated inflammation.

Main Methods:

  • Utilized differentiated 3T3-L1 adipocytes and PKCdelta-deficient mouse embryonic fibroblasts (MEFs).
  • Treated cells with IL-6 and/or insulin, with or without the PKCdelta inhibitor rottlerin.
  • Analyzed gene expression via real-time PCR and protein phosphorylation/localization via immunoblotting.

Main Results:

  • PKCdelta inhibition or deficiency significantly reduced STAT3 phosphorylation at Ser-727 and Tyr-705.
  • Reduced STAT3 nuclear translocation and subsequent transcription of inflammatory genes (SAA3, Hp, Il6, Socs3).
  • PKCdelta nuclear translocation upon IL-6 stimulation was observed and inhibited by rottlerin.

Conclusions:

  • PKCdelta plays a pivotal role in mediating IL-6-induced inflammatory gene expression in adipose cells.
  • PKCdelta is essential for IL-6-induced STAT3 activation and nuclear translocation.
  • PKCdelta represents a promising molecular target for developing anti-inflammatory therapies.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...